Search Results - "Ward, Mark P."

Platelets, immune cells and the coagulation cascade; friend or foe of the circulating tumour cell? by Ward, Mark P, E Kane, Laura, A Norris, Lucy, Mohamed, Bashir M, Kelly, Tanya, Bates, Mark, Clarke, Andres, Brady, Nathan, Martin, Cara M, Brooks, Robert D, Brooks, Doug A, Selemidis, Stavros, Hanniffy, Sean, Dixon, Eric P, A O'Toole, Sharon, J O'Leary, John

“…Cancer cells that transit from primary tumours into the circulatory system are known as circulating tumour cells (CTCs). These cancer cells have unique…”
Get full text

Ex vivo expansion of circulating tumour cells (CTCs) by Mohamed, Bashir M., Ward, Mark P., Bates, Mark, Spillane, Cathy D., Kelly, Tanya, Martin, Cara, Gallagher, Michael, Heffernan, Sheena, Norris, Lucy, Kennedy, John, Saadeh, Feras Abu, Gleeson, Noreen, Brooks, Doug A., Brooks, Robert D., Selemidis, Stavros, O’Toole, Sharon, O’Leary, John J.

“…Circulating tumour cells (CTCs) are a critical intermediate step in the process of cancer metastasis. The reliability of CTC isolation/purification has limited…”
Get full text

Could MicroRNAs Be Useful Tools to Improve the Diagnosis and Treatment of Rare Gynecological Cancers? A Brief Overview by Di Fiore, Riccardo, Suleiman, Sherif, Pentimalli, Francesca, O'Toole, Sharon A, O'Leary, John J, Ward, Mark P, Conlon, Neil T, Sabol, Maja, Ozretić, Petar, Erson-Bensan, Ayse Elif, Reed, Nicholas, Giordano, Antonio, Herrington, C Simon, Calleja-Agius, Jean

“…Gynecological cancers pose an important public health issue, with a high incidence among women of all ages. Gynecological cancers such as malignant germ-cell…”
Get full text

An Overview of the Role of Long Non-Coding RNAs in Human Choriocarcinoma by Di Fiore, Riccardo, Suleiman, Sherif, Felix, Ana, O’Toole, Sharon A., O’Leary, John J., Ward, Mark P., Beirne, James, Sabol, Maja, Ozretić, Petar, Yordanov, Angel, Vasileva-Slaveva, Mariela, Kostov, Stoyan, Nikolova, Margarita, Said-Huntingford, Ian, Ayers, Duncan, Ellul, Bridget, Pentimalli, Francesca, Giordano, Antonio, Calleja-Agius, Jean

“…Choriocarcinoma (CC), a subtype of trophoblastic disease, is a rare and highly aggressive neoplasm. There are two main CC subtypes: gestational and…”
Get full text

LncRNA MORT (ZNF667-AS1) in Cancer—Is There a Possible Role in Gynecological Malignancies? by Di Fiore, Riccardo, Suleiman, Sherif, Drago-Ferrante, Rosa, Felix, Ana, O’Toole, Sharon A., O’Leary, John J., Ward, Mark P., Beirne, James, Yordanov, Angel, Vasileva-Slaveva, Mariela, Subbannayya, Yashwanth, Pentimalli, Francesca, Giordano, Antonio, Calleja-Agius, Jean

“…Gynecological cancers (GCs) are currently among the major threats to female health. Moreover, there are different histologic subtypes of these cancers, which…”
Get full text

A risk score for prediction of venous thromboembolism in gynecologic cancer: The Thrombogyn score by Norris, Lucy A., Ward, Mark P., O'Toole, Sharon A., Marchocki, Zibi, Ibrahim, Nadia, Khashan, Ali S., Abu Saadeh, Feras, Gleeson, Noreen

“…Gynecologic cancers are associated with high rates of venous thromboembolism (VTE), which is exacerbated by pelvic surgery and chemotherapy. The aim of this…”
Get full text

The induction of a mesenchymal phenotype by platelet cloaking of cancer cells is a universal phenomenon by Spillane, Cathy D., Cooke, Niamh M., Ward, Mark P., Kenny, Dermot, Blackshields, Gordon, Kelly, Tanya, Bates, Mark, Huang, Yanmei, Martin, Cara, Skehan, Sinead, Canney, Aoife, Gallagher, Michael, Smyth, Paul, Brady, Nathan, Clarke, Andres, Mohamed, Bashir, Norris, Lucy, Brooks, Doug A., Brooks, Robert D., Heatlie, Jessica K., Selemidis, Stavros, Hanniffy, Sean, Dixon, Eric, Sheils, Orla, O'Toole, Sharon A., O'Leary, John J.

“…•Platelet cancer cell interactions are a key factor in driving the pro-metastatic phenotype.•Platelet cancer cell interactions appear to be mediated by 5 key…”
Get full text

Plasminogen activator inhibitor 1 is associated with high-grade serous ovarian cancer metastasis and is reduced in patients who have received neoadjuvant chemotherapy by Kelly, Tanya E, Spillane, Cathy L, Ward, Mark P, Hokamp, Karsten, Huang, Yanmei, Tewari, Prerna, Martin, Cara M, Norris, Lucy A, Mohamed, Bashir M, Bates, Mark, Brooks, Robert, Selemidis, Stavros, Brooks, Douglas A, Kamran, Waseem, Saadeh, Feras Abu, O'Toole, Sharon A, O'Leary, John J

“…High-grade serous ovarian cancer (HGSOC) is the most prevalent and deadliest subtype of epithelial ovarian cancer (EOC), killing over 140,000 people annually…”
Get full text

How CSL Biotech became a global player: getting ahead of the competition by Ward, Mark P., Osiyevskyy, Oleksiy

“…Purpose This paper aims to examine the role strategic problem identification and resolution played in identifying and capturing new sources of competitive…”
Get full text

Potential role of the CD39-CD73 ATP-adenosine pathway in platelet mediated dissemination of circulating tumour cells by Ward, Mark P., O’Toole, Sharon A., O’Leary, John J.

Get full text

Extracellular vesicles in ovarian cancer - A role in venous thromboembolism? by Ward, Mark P.

Get full text

Circulating tumour cells: The Good, the Bad and the Ugly by Bates, Mark, Mohamed, Bashir M., Ward, Mark P., Kelly, Tanya E., O’Connor, Roisin, Malone, Victoria, Brooks, Robert, Brooks, Doug, Selemidis, Stavros, Martin, Cara, O’Toole, Sharon, O’Leary, John J.

“…This review is an overview of the current knowledge regarding circulating tumour cells (CTCs), which are potentially the most lethal type of cancer cell, and…”
Get full text

Unravelling the biological and clinical challenges of circulating tumour cells in epithelial ovarian carcinoma by Lewis, Faye, Beirne, James, Henderson, Brian, Norris, Lucy, Cadoo, Karen, Kelly, Tanya, Martin, Cara, Hurley, Sinéad, Kanjuga, Marika, O'Driscoll, Lorraine, Gately, Kathy, Oner, Ezgi, Saini, Volga M., Brooks, Doug, Selemidis, Stavros, Kamran, Waseem, Haughey, Niamh, Maguire, Patrick, O'Gorman, Catherine, Saadeh, Feras Abu, Ward, Mark P., O'Leary, John J., O'Toole, Sharon A.

“…Epithelial ovarian carcinoma (EOC) is the eighth most common cancer in women and the leading cause of gynaecological cancer death, predominantly due to the…”
Get full text

Procoagulant activity in high grade serous ovarian cancer patients following neoadjuvant chemotherapy-The role of the activated protein C pathway by Ward, Mark P., Saadeh, Feras Abu, O'Toole, Sharon A., O'Leary, John J., Gleeson, Noreen, Norris, Lucy A.

“…Ovarian cancer patients are at high risk of thrombosis particularly during chemotherapy treatment however the mechanism is not understood. The aim of this…”
Get full text

A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer by M Saini, Volga, Oner, Ezgi, Ward, Mark P, Hurley, Sinead, Henderson, Brian David, Lewis, Faye, Finn, Stephen P, Fitzmaurice, Gerard J, O'Leary, John J, O'Toole, Sharon, O'Driscoll, Lorraine, Gately, Kathy

“…Circulating tumor cells (CTCs) have potential as diagnostic, prognostic, and predictive biomarkers in solid tumors. Despite Food and Drug Administration (FDA)…”
Get full text

(In)Distinctive Role of Long Non-Coding RNAs in Common and Rare Ovarian Cancers by Sabol, Maja, Calleja-Agius, Jean, Di Fiore, Riccardo, Suleiman, Sherif, Ozcan, Sureyya, Ward, Mark P., Ozretić, Petar

“…Rare ovarian cancers (ROCs) are OCs with an annual incidence of fewer than 6 cases per 100,000 women. They affect women of all ages, but due to their low…”
Get full text

Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression by Lazniewska, Joanna, Li, Ka Lok, Johnson, Ian R. D., Sorvina, Alexandra, Logan, Jessica M., Martini, Carmela, Moore, Courtney, Ung, Ben S.-Y., Karageorgos, Litsa, Hickey, Shane M., Prabhakaran, Sarita, Heatlie, Jessica K., Brooks, Robert D., Huzzell, Chelsea, Warnock, Nicholas I., Ward, Mark P., Mohammed, Bashir, Tewari, Prerna, Martin, Cara, O’Toole, Sharon, Edgerton, Laura Bogue, Bates, Mark, Moretti, Paul, Pitson, Stuart M., Selemidis, Stavros, Butler, Lisa M., O’Leary, John J., Brooks, Douglas A.

“…Prostate cancer (PCa) development and progression relies on the programming of glucose and lipid metabolism, and this involves alterations in androgen receptor…”
Get full text

Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1 by Logan, Jessica M, Hopkins, Ashley M, Martini, Carmela, Sorvina, Alexandra, Tewari, Prerna, Prabhakaran, Sarita, Huzzell, Chelsea, Johnson, Ian R D, Hickey, Shane M, Ung, Ben S-Y, Lazniewska, Joanna, Brooks, Robert D, Moore, Courtney R, Caruso, Maria C, Karageorgos, Litsa, Martin, Cara M, O'Toole, Sharon, Bogue Edgerton, Laura, Ward, Mark P, Bates, Mark, Selemidis, Stavros, Esterman, Adrian, Heffernan, Sheena, Keegan, Helen, Ní Mhaolcatha, Sarah, O'Connor, Roisin, Malone, Victoria, Carter, Marguerite, Ryan, Katie, Clarke, Andres, Brady, Nathan, Klebe, Sonja, Samaratunga, Hemamali, Delahunt, Brett, Sorich, Michael J, Moretti, Kim, Butler, Lisa M, O'Leary, John J, Brooks, Douglas A

“…Gleason scoring is used within a five-tier risk stratification system to guide therapeutic decisions for patients with prostate cancer. This study aimed to…”
Get full text

BAG3 promotes tumour cell proliferation by regulating EGFR signal transduction pathways in triple negative breast cancer by Shields, Sarah, Conroy, Emer, O'Grady, Tony, McGoldrick, Alo, Connor, Kate, Ward, Mark P, Useckaite, Zivile, Dempsey, Eugene, Reilly, Rebecca, Fan, Yue, Chubb, Anthony, Matallanas, David Gomez, Kay, Elaine W, O'Connor, Darran, McCann, Amanda, Gallagher, William M, Coppinger, Judith A

“…Triple-negative breast cancer (TNBC), is a heterogeneous disease characterised by absence of expression of the estrogen receptor (ER), progesterone receptor…”
Get full text

Correction: BAG3 promotes tumour cell proliferation by regulating EGFR signal transduction pathways in triple negative breast cancer by Shields, Sarah, Conroy, Emer, O'Grady, Tony, McGoldrick, Alo, Connor, Kate, Ward, Mark P, Useckaite, Zivile, Dempsey, Eugene, Reilly, Rebecca, Fan, Yue, Chubb, Anthony, Matallanas, David Gomez, Kay, Elaine W, O'Connor, Darran, McCann, Amanda, Gallagher, William M, Coppinger, Judith A

“…[This corrects the article DOI: 10.18632/oncotarget.24590.]…”
Get full text